SCHEMBL8434859

SCHEMBL8434859

Clc1ccc[c]c1-c1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.50
CYP1A2 P05177 4/20 0.50
RORC P51449 1/20 0.38
RORB Q92753 1/20 0.38
TYMP P19971 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
ATM Q13315 1/20 0.37
PTPN1 P18031 1/20 0.34
ALPL P05186 1/20 0.34
GAA P10253 1/20 0.34
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 2/20 0.34
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
P2RX7 Q99572 1/20 0.33
NISCH Q9Y2I1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669469 0.83 CYP2A6 (0.40) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL18258983 0.81 CYP2A6 (0.39) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL646330 0.81 ALDH1A1 (0.42) CYP2A6CYP1A2TYMPKDM4EALDH1A1
SCHEMBL3990580 0.81 CYP2A6 (0.44) CYP2A6KDM4EALDH1A1HSD17B10RAB9A
SCHEMBL9614637 0.79 ALDH1A1 (0.50) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL18957552 0.79 KDM4E (0.38) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL3841865 0.79 CYP1A2 (0.50) CYP1A2KDM4EALDH1A1HSD17B10CYP2C19
SCHEMBL668681 0.79 MAPT (0.42) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL8360620 0.78 MCL1 (0.35) CYP2A6CYP1A2KDM4EHSD17B10PTPN1
SCHEMBL9223446 0.78 CYP1A2 (0.43) CYP2A6CYP1A2RORCRORBTYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5945422-A ANTICANCER AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS WARNER-LAMBERT COMPANY (US) 1999-08-31 US disclosed